Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A randomized trial assessing the Five-Day Plan for smoking cessation.

Raymond Romand1, Sophie Gourgou, Hélène Sancho-Garnier

  • 1Université Louis Pasteur, Illkirch , France. romand@igbmc.u-strasbg.fr

Addiction (Abingdon, England)
|September 28, 2005
PubMed
Summary

The Five-Day Plan (FDP) significantly increased smoking cessation rates compared to a brief intervention. This behavioral program offers a viable aid for smokers aiming to quit tobacco use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Gutierrez et al. concerning the 5-year local recurrence-free survival (L-RFS) rate after a second breast conserving surgery and intraoperative radiotherapy (IORT).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.

Journal of the National Cancer Institute·2026
Same author

National Congress of Clinical Epidemiology (EPICLIN) - 20th edition.

Journal of epidemiology and population health·2026
Same author

Feasibility and safety of repeat breast-conserving surgery with intraoperative irradiation for local breast carcinoma recurrences: A phase 2 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Electrophysiological study of the ototoxicity of kanamycin during development in guinea pigs.

Hearing research·2026
Same author

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Area of Science:

  • Public Health
  • Behavioral Science
  • Addiction Medicine

Background:

  • Smoking remains a leading cause of preventable morbidity and mortality worldwide.
  • Effective smoking cessation interventions are crucial for public health initiatives.
  • Behavioral therapies play a significant role in supporting individuals to quit smoking.

Purpose of the Study:

  • To evaluate the effectiveness of the Five-Day Plan (FDP) as a smoking cessation aid.
  • To compare the FDP's efficacy against a minimal intervention for smokers.
  • To assess long-term abstinence rates following the intervention.

Main Methods:

  • A randomized controlled trial was conducted across six towns in France.
  • 228 adult smokers willing to quit were recruited.

Related Experiment Videos

  • Participants were randomized to either the FDP (behavioral group therapy) or a control group (single health effects session).
  • Main Results:

    • The FDP group achieved significantly higher 12-month continuous abstinence rates (13%) compared to the control group (3%, P = 0.004).
    • Initial quit rates at the end of the FDP were 56% in the intervention group versus 13% in the control group.
    • Self-reported abstinence rates at 3 and 6 months also favored the FDP intervention.

    Conclusions:

    • The Five-Day Plan (FDP) demonstrates significant effectiveness in aiding smokers to achieve long-term cessation.
    • The FDP is a valuable behavioral intervention for individuals seeking to quit smoking.
    • Further implementation of the FDP can contribute to reducing the burden of smoking-related diseases.